Determining if a product requires registration with EPA is not always an easy process due to the ever-changing regulatory landscape. However, TSG’s regulatory consultants routinely review product claims, use sites and ingredients to determine if the proposed product requires registration as a pesticide with EPA.

If a product falls under EPA’s pesticide registration requirement, TSG can assist your company in developing product registration strategies, preparing and submitting federal and state registrations, and supporting the product post-EPA registration through product life-cycle management. Our regulatory consultants will work with you to identify the data applicable to your registration, then along with TSG’s scientific consultants, provide guidance on addressing each data requirement. TSG frequently assists clients in developing EPA pesticide labels as well as completing the necessary administrative paperwork to support the proposed product application. TSG can submit product applications to EPA on your company’s behalf and will act as your advocate during communications with EPA throughout the registration process, supporting your application from beginning to end.

Plant biostimulants are a growing industry within the naturally-occurring substance arena. Some of the claims commonly found on plant biostimulant labels could be considered as plant growth regulator claims, which would require registration as pesticides under FIFRA. EPA’s draft guidance aims to provide direction as to the claims that trigger EPA pesticide registration as well as known active ingredients that require registration as pesticides with EPA. Although the guidance is currently in draft form and Industry representatives are working with EPA to address concerns, it is important for registrants to be aware of EPA guidance that could potentially impact their existing product line, marketing strategy, budgets and timelines. TSG is following the discussions revolving around the draft guidance closely and can assist registrants with assessing their products in light of the draft guidance. For further information, download our paper on navigating the U.S. regulatory landscape for biostimulants.